BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2788375)

  • 21. Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen.
    Bonura A; Gulino L; Trapani A; Di Felice G; Tinghino R; Amoroso S; Geraci D; Valenta R; Westritschnig K; Scala E; Mari A; Colombo P
    Mol Immunol; 2008 May; 45(9):2465-73. PubMed ID: 18289680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory activity of fenoterol on Dermatophagoides-, Parietaria-, tetanus-toxoid-, and Candida albicans-stimulated blood mononuclear cells: differences in beta2-adrenoreceptor stimulation but not in cell apoptosis.
    Silvestri M; Oddera S; Scarso L; Pistoia V; Tasso P; Rossi GA
    J Asthma; 2000 May; 37(3):281-90. PubMed ID: 10831153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of Parietaria judaica pollen and allergen profiling by an immunoproteomic approach.
    Barranca M; Fontana S; Taverna S; Duro G; Zanella-Cleon I; Becchi M; De Leo G; Alessandro R
    Biotechnol Lett; 2010 Apr; 32(4):565-70. PubMed ID: 19953298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parietaria judaica and dermo-respiratory allergy in Barcelona: a study of 250 cases.
    Valero Santiago A; Malet i Casajuana A; García Calderón PA
    Allergol Immunopathol (Madr); 1988; 16(4):209-14. PubMed ID: 2465679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity to Parietaria pollen in the Southampton area as determined by skin-prick and RAST tests.
    Holgate ST; Jackson L; Watson HK; Ganderton MA
    Clin Allergy; 1988 Nov; 18(6):549-56. PubMed ID: 3242974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The allergens of Parietaria.
    Colombo P; Bonura A; Costa M; Izzo V; Passantino R; Locorotondo G; Amoroso S; Geraci D
    Int Arch Allergy Immunol; 2003 Mar; 130(3):173-9. PubMed ID: 12660421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
    J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of a novel aminopeptidase from the pollen of Parietaria judaica that alters epithelial integrity and degrades neuropeptides.
    Cortes L; Carvalho AL; Todo-Bom A; Faro C; Pires E; Veríssimo P
    J Allergy Clin Immunol; 2006 Oct; 118(4):878-84. PubMed ID: 17030241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen.
    De Palma R; Wu S; Sallusto F; Di Felice G; Martucci P; Geraci D; Colombo P; Troise C; Sacerdoti G; Nocera A; Gorski J
    J Immunol; 1999 Feb; 162(4):1982-7. PubMed ID: 9973468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.
    Würtzen PA; van Neerven RJ; Arnved J; Ipsen H; Sparholt SH
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):241-9. PubMed ID: 9500758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.
    Imada M; Simons FE; Jay FT; Hayglass KT
    Immunology; 1995 Jul; 85(3):373-80. PubMed ID: 7558124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of both TCR repertoire and severity of the atopic status on the cytokine secretion profile of Parietaria officinalis-specific T cells.
    Parronchi P; Sampognaro S; Annunziato F; Brugnolo F; Radbruch A; Di Modugno F; Ruffilli A; Romagnani S; Maggi E
    Eur J Immunol; 1998 Jan; 28(1):37-46. PubMed ID: 9485184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic activity of nonpollen parts (leaves and stems) of allergenic plants (Parietaria judaica and Dactylis glomerata).
    D'Amato G; De Palma R; Verga A; Martucci P; Liccardi G; Lobefalo G
    Ann Allergy; 1991 Oct; 67(4):421-4. PubMed ID: 1952298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivity between Parietaria species using the major rParj1 and rParj2 allergens.
    Bonura A; Artale A; Marino M; Amoroso S; Marcucci F; Geraci D; Colombo P
    Allergy Asthma Proc; 2006; 27(5):378-82. PubMed ID: 17063667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination.
    Bonura A; Corinti S; Artale A; Di Felice G; Amoroso S; Melis M; Geraci D; Colombo P
    Int Arch Allergy Immunol; 2007; 142(4):274-84. PubMed ID: 17124429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity between Parietaria judaica and Parietaria officinalis.
    Corbi AL; Pelaez A; Errigo E; Carreira J
    Ann Allergy; 1985 Feb; 54(2):142-7. PubMed ID: 3970390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Parietaria judaica pollen extract on human microvascular endothelial cells.
    Taverna S; Flugy A; Colomba P; Barranca M; De Leo G; Alessandro R
    Biochem Biophys Res Commun; 2008 Aug; 372(4):644-9. PubMed ID: 18515075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sensitization against Parietaria pollen in a group of 1143 patients in the Brescian area].
    Tosoni C; Apollonio A; Carabellese N; Martinelli M; Prandini P; Soldati F; Coccaglio R; Duse M; Cattaneo R
    Boll Ist Sieroter Milan; 1988; 67(3):202-6. PubMed ID: 3242557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivity of T cells with grass pollen allergen extract and allergoid.
    Kahler H; Stüwe H; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 1999 Oct; 120(2):146-57. PubMed ID: 10545769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy and safety of two preseasonal regimens of glutaraldehyde modified, tyrosine-adsorbed parietaria pollen extract over a period of three years in monosensitive patients.
    Negro JM; Wheeler AW; Hernández J; Youlten LJ; Pascual A; García-Sellés FJ; Pagán JA; López-Sánchez JD; Miralles JC; Sarrió F; Milán JM; Contreras LG; Vidal D
    Allergol Immunopathol (Madr); 1999; 27(3):153-64. PubMed ID: 10431101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.